Literature DB >> 8769151

Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.

S Suzuki1, X K Li, T Shinomiya, S Enosawa, T Kakefuda, M Mitsusada, H Amemiya, S Takahara, M Amari, S Naoe, Y Hoshino, K Chiba.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8769151

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Yanxia Ye; Bing Song; Xinqiang Lai; Yaoying Zeng
Journal:  Inflamm Res       Date:  2012-03-10       Impact factor: 4.575

2.  Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

Authors:  Jerold Chun; Yasuyuki Kihara; Deepa Jonnalagadda; Victoria A Blaho
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

3.  The role of sphingosine 1-phosphate in immunity and sepsis.

Authors:  Markus H Gräler
Journal:  Am J Clin Exp Immunol       Date:  2012-09-27

4.  Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo.

Authors:  Margarita Dominguez-Villar; Khadir Raddassi; Ann Caroline Danielsen; Joseph Guarnaccia; David A Hafler
Journal:  J Autoimmun       Date:  2018-08-16       Impact factor: 7.094

5.  Severe murine limb-girdle muscular dystrophy type 2C pathology is diminished by FTY720 treatment.

Authors:  Ahlke Heydemann
Journal:  Muscle Nerve       Date:  2017-03-26       Impact factor: 3.217

6.  FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

Authors:  Qing Liu; Xiaobin Zhao; Frank Frissora; Yihui Ma; Ramasamy Santhanam; David Jarjoura; Amy Lehman; Danilo Perrotti; Ching-Shih Chen; James T Dalton; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2007-08-29       Impact factor: 22.113

Review 7.  Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod.

Authors:  Safura Pournajaf; Leila Dargahi; Mohammad Javan; Mohammad Hossein Pourgholami
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.